27 related articles for article (PubMed ID: 7780871)
1. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
[TBL] [Abstract][Full Text] [Related]
2. Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up.
Klem I; Wehinger C; Schneider B; Hartl E; Finsterer J; Stöllberger C
Diabetes Metab Res Rev; 2003; 19(4):320-8. PubMed ID: 12879410
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.
Vaziri SM; Larson MG; Benjamin EJ; Levy D
Circulation; 1994 Feb; 89(2):724-30. PubMed ID: 8313561
[TBL] [Abstract][Full Text] [Related]
4. Non-rheumatic atrial fibrillation and stroke.
Tonkin A
Aust N Z J Med; 1999 Jun; 29(3):467-72. PubMed ID: 10868521
[TBL] [Abstract][Full Text] [Related]
5. Nonrheumatic atrial fibrillation: a brief overview.
Haraphongse M; Haraphongse Y; Montague TJ
Can J Cardiol; 1995 Jun; 11(6):498-502. PubMed ID: 7780871
[TBL] [Abstract][Full Text] [Related]
6. [Atrial fibrillation and stroke].
Mattle HP; Schwerzmann M; Seiler Ch
Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
[TBL] [Abstract][Full Text] [Related]
7. [The clinical challenge of the atrial fibrillation].
de Berrazueta Fernández JR
An R Acad Nac Med (Madr); 2007; 124(2):361-78. PubMed ID: 18069601
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.
Schmitt J; Duray G; Gersh BJ; Hohnloser SH
Eur Heart J; 2009 May; 30(9):1038-45. PubMed ID: 19109347
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation: diagnosis and treatment.
Gutierrez C; Blanchard DG
Am Fam Physician; 2011 Jan; 83(1):61-8. PubMed ID: 21888129
[TBL] [Abstract][Full Text] [Related]
10. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Ahmad Y; Lip GY
Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
